Astrazeneca (AZN) Revenue and Net Income History

Historical revenue, operating income and net income for Astrazeneca (AZN) over the last 10 years. The current TTM revenue for Astrazeneca as of January 12, 2018 is $23B.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $90.282B $23.002B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.